# Study of Topical Ocular PAN-90806 in PDR

> **NCT02475109** · PHASE1 · COMPLETED · sponsor: **PanOptica, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** PAN-90806 Ophthalmic Solution

## Key facts

- **NCT ID:** NCT02475109
- **Lead sponsor:** PanOptica, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475109, "Study of Topical Ocular PAN-90806 in PDR". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02475109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*